Fresenius Medical Care AG I (FME.DE)
Operates dialysis clinics and makes kidney treatment machines and medications worldwide.
43.27-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-0.0%
The outlook
FME.DE is trading above both its 50- and 200-day moving averages, positioning it in the middle-to-upper range of its 52-week band. Analyst sentiment leans toward Hold with thin conviction across 17 analysts, and the average price target sits roughly 1% above the current level. The stock's valuation at 13.2x trailing earnings appears modest relative to its technical positioning.
What’s behind the score
Analyst consensusHold — 2.9 avg of 17 analysts
Price trendAbove its 50- & 200-day averages
52-week range65% of the way from its 52-week low to high
Price targetAvg target +1% vs current price
Analyst price target
~12-month · 17 analysts43.78average target+1.2% vs now
Now 43.27
Low 31.00High 67.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
47.86
52-wk low
34.57
50-day avg
40.20
200-day avg
39.97
Trailing P/E
13.2